Flu vaccine could one day be used to treat cancer
An early study in mice, published in Proceedings of the National [...]
Integrative oncology: using evidence-based medicine to improve patient outcomes and quality of life
A recent article published in Cancer Therapy Advisor describes what [...]
ABPI Patient Organisation Forum: Patient centricity
KCSN is a member of the Association of the British [...]
First-line treatment of papillary renal cell carcinoma with sunitinib
Papillary renal cell carcinoma (PRCC) is a rare subtype of [...]
NICE draft guidance refuses pembrolizumab plus axitinib combination
The National Institute for Health and Care Excellence (NICE) have issued [...]
New risk scoring system for metastatic kidney cancer
The treatment options for metastatic renal cell carcinoma (RCC) have [...]
Nephrectomy after complete response to immunotherapy
A retrospective study looked at the clinical and surgical outcomes [...]
Cancer vaccine could ‘boost’ immunotherapy effectiveness
A major new study has discovered a means to increase [...]
Atezolizumab and bevacizumab in patients with advanced non-clear cell renal cell carcinoma
Dr Rana McKay from University of California in San Diego, [...]
Selecting therapy for poor-risk advanced kidney cancer
In this video interview, Dr Earle Burgess from the Levine [...]
